Dr. Matthew Hong

Claim this profile

M3 Wake Research Inc

Studies Coronavirus
Studies Respiratory Syncytial Virus
4 reported clinical trials
12 drugs studied

Affiliated Hospitals

Image of trial facility.
M3 Wake Research, Inc.

More about Matthew Hong

Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 0 Active Clinical Trials
Treatments Matthew Hong has experience with
  • NVX-CoV2373
  • NVX-CoV2601
  • NVX-CoV2540
  • RSVPreF3 OA Investigational Vaccine
  • Placebo
  • Product A: Non-Combusted Cigarette Variant 42001402 And Product Use Mode B

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Hong specialize in?
Matthew Hong focuses on Coronavirus and Respiratory Syncytial Virus. In particular, much of their work with Coronavirus has involved treating patients, or patients who are undergoing treatment.
Is Matthew Hong currently recruiting for clinical trials?
No, Matthew Hong is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Matthew Hong has studied deeply?
Yes, Matthew Hong has studied treatments such as NVX-CoV2373, NVX-CoV2601, NVX-CoV2540.
What is the best way to schedule an appointment with Matthew Hong?
Apply for one of the trials that Matthew Hong is conducting.
What is the office address of Matthew Hong?
The office of Matthew Hong is located at: M3 Wake Research Inc, Raleigh, North Carolina 27612 United States. This is the address for their practice at the M3 Wake Research Inc.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.